Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.44
-0.08 (-1.45%)
Jun 16, 2025, 4:00 PM - Market closed
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $484.93 million as of June 16, 2025. Its market cap has increased by 326.99% in one year.
Market Cap
484.93M
Enterprise Value
282.24M
1-Year Change
326.99%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $484.93M, a decrease of -54.65%. That is a compound annual growth rate of -20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 492.06M | 91.20% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.99B |
| Johnson & Johnson | 373.47B |
| Novo Nordisk | 343.59B |
| AbbVie | 337.14B |
| UnitedHealth Group | 279.09B |
| Abbott Laboratories | 233.16B |
| Novartis AG | 232.80B |
| AstraZeneca | 228.09B |